Plant-based Vaccine Market By Clinical Trial (Phase I, Phase II, Others); By Type (Bacterial/ Agrobacterial vaccines, Transgenic, Viral Vaccines, Fungal Vaccines, Recombinant subunit vaccines, Parasitic Vaccines, Others); By Source (Tobacco, potato, Maize, Nicotiana benthamiana, Carrot cells, tobacco cells, Strawberry, Rice, Lettuce, Spinach, Others); By Disease Indication (Enterotoxigenic E. coli, Ebola virus (SUDV, ZEBOV, Côte d’Ivoire ebolavirus, Bundibugyo ebolavirus), Norovirus, Hepatitis B virus, Rabies, Influenza (H1N1, H7N9, Others), Cholera, Respiratory Syndromes, Cancer, Others); By Mode of Administration (Intramuscular, Oral Administration, Others); By End Users (Hospitals, Clinics, Primary Care Centers, Others); By Region (U.S., Canada, Mexico, Rest of North America, France, UK, Spain, Germany, Italy, Nordic Countries , Benelux Union, Rest of Europe, China, Japan, India, New Zealand, Australia, South Korea, Southeast Asia (Singapore, Philippines, Indonesia, Thailand, Malaysia, Vietnam, Rest of Southeast Asia), Brazil, Argentina, Rest of Latin America, Saudi Arabia, UAE, Egypt, Kuwait, South Africa, Rest of Middle East & Africa) – Global Insights, Growth, Size, Comparative Analysis, Trends and Forecast, 2020 - 2028